Clinical Trials Browser

OTHER × Interventional × Gaucher Disease × Clear all

NCT03721068 2025-09-09

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Phase 1 Recruiting

18 enrolled

CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

NCT01586455 2022-10-25

HPDSC

Phase 1 Completed

43 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Adrenoleukodystrophy, Anemia, Aplastic, Fucosidosis, Gaucher Disease, Leukodystrophy, Globoid Cell, Leukodystrophy, Metachromatic, Mucopolysaccharidosis I, Metabolism, Inborn Errors, Mucopolysaccharidosis VI, Myelodysplastic Syndromes, Neuronal Ceroid-Lipofuscinoses, Niemann-Pick Diseases, Wolman Disease, Leukemia, Myeloid, Acute, Anemia, Diamond-Blackfan, X-Linked Combined Immunodeficiency Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04637503 2020-11-19

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Phase 1/2 Unknown

100 enrolled

CNS

Gaucher Disease, Neuroblastoma